{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Arber DA"],"funding":["Medical Research Council","NHLBI NIH HHS","National Institute for Health Research (NIHR)","NCI NIH HHS"],"pagination":["1200-1228"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9479031"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["140(11)"],"pubmed_abstract":["The classification of myeloid neoplasms and acute leukemias was last updated in 2016 within a collaboration between the World Health Organization (WHO), the Society for Hematopathology, and the European Association for Haematopathology. This collaboration was primarily based on input from a clinical advisory committees (CACs) composed of pathologists, hematologists, oncologists, geneticists, and bioinformaticians from around the world. The recent advances in our understanding of the biology of hematologic malignancies, the experience with the use of the 2016 WHO classification in clinical practice, and the results of clinical trials have indicated the need for further revising and updating the classification. As a continuation of this CAC-based process, the authors, a group with expertise "],"journal":["Blood"],"pubmed_title":["International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data."],"pmcid":["PMC9479031"],"funding_grant_id":["MC_U137961146","1514301","1779543","P30 CA008748","NF-SI-0617-10056","MC_UU_00029/8","MC_UU_00016/11","MR/L008963/1","G1000729","MC_UU_12009/11","P01 CA066996","G1000801c","T32 HL007574","MC_PC_19049"],"pubmed_authors":["Dombret H","Kiladjian JJ","Gokbuget N","Pui CH","Loh ML","Ebert BL","Tallman MS","Borowitz MJ","Branford S","Stone RM","Duncavage EJ","Rudelius M","Tzankov A","Arber DA","Larson RA","Odenike OM","Hellstrom-Lindberg E","Wierzbowska A","Vannucchi AM","Cortes JE","Wei AH","Tien HF","Hoffman R","Hobbs GS","Jabbour EJ","Macintyre E","Schiffer CA","Cazzola M","Gianelli U","Weinberg OK","Lowenberg B","Papaemmanuil E","Savona MR","Shimamura A","Radich JP","Kvasnicka HM","DiNardo CD","Le Beau MM","Ogawa S","Rozman M","Estey EH","Niemeyer C","Bagg A","Porkka K","Thiele J","Orfao A","Godley LA","Vyas P","Tefferi A","Stock WA","Gotlib J","Dohner H","Calvo KR","Orazi A","Wang SA","Gangat N","Bueso-Ramos CE","Facchetti F","Hasserjian RP","Mullighan CG","Reiter A","Barbui T","Passamonti F","Sierra J","Dal Cin P","Malcovati L","Schmitt-Graeff A","Foucar K"],"additional_accession":[]},"is_claimable":false,"name":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.","description":"The classification of myeloid neoplasms and acute leukemias was last updated in 2016 within a collaboration between the World Health Organization (WHO), the Society for Hematopathology, and the European Association for Haematopathology. This collaboration was primarily based on input from a clinical advisory committees (CACs) composed of pathologists, hematologists, oncologists, geneticists, and bioinformaticians from around the world. The recent advances in our understanding of the biology of hematologic malignancies, the experience with the use of the 2016 WHO classification in clinical practice, and the results of clinical trials have indicated the need for further revising and updating the classification. As a continuation of this CAC-based process, the authors, a group with expertise ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2026-06-11T06:38:09.889Z","creation":"2025-04-06T02:24:25.932Z"},"accession":"S-EPMC9479031","cross_references":{"pubmed":["35767897"],"doi":["10.1182/blood.2022015850"]}}